Multifaceted Presentations of Dengue Virus Infection and Its Management: A Case Series

Rafiq Shajahan^1, , Puay Sheng Hwa¹, Choe Yee Xian¹, Naganathan Pillai¹ and Ganesh Kasinathan²

¹Department of Medicine, Monash University Malaysia Sunway Campus, Selangor, Malaysia

²Department of Medicine, Segamat Hospital, KM6 Jalan Genuang, Segamat, Johor, Malaysia

Cite this paper:
Rafiq Shajahan, Puay Sheng Hwa, Choe Yee Xian, Naganathan Pillai and Ganesh Kasinathan. Multifaceted Presentations of Dengue Virus Infection and Its Management: A Case Series. American Journal of Epidemiology and Infectious Disease. 2015; 3(5):103-111. doi: 10.12691/ajeid-3-5-3

Abstract

Introduction: Dengue fever is a viral infection that encompasses a broad spectrum of systemic manifestations ranging from self-limiting febrile episodes to features of severe dengue (SD), dengue hemorrhagic fever (DHF) and dengue shock syndrome(DSS) that may lead to rapid deterioration and eventually death. It is a major international public health concern due to its increasing morbidity and mortality in all age groups. Background: We describe four different groups of dengue which require distinct management plan pertaining to their severity of presentation. The first case reports a young patient who was managed on an outpatient basis. The second case illustrates dengue in pregnancy which required induction of labor due to fetal distress during the febrile phase. The third patient was an elderly lady who had multiple co-morbidities with significant metabolic acidosis. The fourth patient involved a presentation of severe dengue shock syndrome associated with massive plasma leakage, multi-organ failure and massive hemorrhage. Conclusion: Early diagnosis of dengue fever is imperative in assisting the patient’s navigation through the critical phase of this illness.

Keywords:
dengue international pregnancy outpatient shock

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. “Dengue virus infection in Africa,” Emerg Infect Dis. 2011; 17(8): 1349-1354.
[2]	Vaughn, D. W. et al. “Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity,” The Journal of infectious diseases. 181, 2-9 (2000).
[3]	Gubler DJ. “The Global Emergence/Resurgence of Arboviral Diseases As Public Health Problems,” Arch Medical Res. 2002; 33(4):330-342.
[4]	Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ. “Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development,”. Curr Infect Dis Rep. 2010; 12(3):157-164.
[5]	Friberg H, Bashyam H, Toyosaki-Maeda T, Potts J, Greenough T, Kalayanarooj S et al. “Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans,” Sci Rep. 2011;1.
[6]	Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. “Dengue and dengue haemorrhagic fever,” Lancet. 1998; 352(9132):971-977.
[7]	Martina B, Koraka P, Osterhaus A. “Dengue Virus Pathogenesis: an Integrated View,” Clinical Microbiology Reviews. 2009; 22(4):564-581.
[8]	Heidemann B, McClure J. “Changes in maternal physiology during pregnancy,” Continuing Education in Anaesthesia, Critical Care & Pain. 2003; 3(3):65-68.
[9]	Ismail NA, Kampan N, Mahdy ZA, Jamil MA, Razi ZR. “Dengue in pregnancy,” Southeast Asian J Trop Med Public Health. 2006; 37(4): 681-683.
[10]	Sharma K, Dadhwal V, Mittal S, Selvi A, Singh N. “A successful management of dengue fever in pregnancy: Report of two cases,” Indian Journal of Medical Microbiology. 2008; 26(4):377.
[11]	Chitra TV, Panicker S. “Maternal and fetal outcome of dengue fever in pregnancy,” J Vector Borne Dis. 2011 Dec; 48(4):210-3.
[12]	Pouliot SH, Xiong X, Harville E, Paz-Soldan V, Tomashek KM, Breart G et al. “Maternal dengue and pregnancy outcomes: a systematic review,” Obstet Gynecol Surv. 2010 Feb; 65(2):107-18.
[13]	Friedman E, Dallah F, Harville E, Myers L, Buekens P, Breart G et al. “Symptomatic Dengue Infection during Pregnancy and Infant Outcomes: A Retrospective Cohort Study,” PLoS Negl Trop Dis. 2014;8(10):e3226.
[14]	Robbins JR, Bakardjiev AI. “Pathogens and the placental fortress,” Curr Opin Microbiol. 2012 Feb; 15(1):36-43.
[15]	Watanaveeradej V, Endy TP, Samakoses R, Kerdpanich A, Simasathien S, Polprasert N et al. “Transplacentally transferred maternal-infant antibodies to dengue virus” Am J Trop Med Hyg. 2003 Aug; 69(2):123-8.
[16]	Chye JK, Lim CT, Ng KB, Lim JM, George R, Lam SK. “Vertical transmission of dengue” Clin Infect Dis. 1997 Dec;25(6):1374-7.
[17]	Rowe E, Leo Y, Wong J, Thein T, Gan V, Lee L et al. “Challenges in Dengue Fever in the Elderly: Atypical Presentation and Risk of Severe Dengue and Hospital Acquired Infection,” PLoS Negl Trop Dis. 2014;8(4):e2777.
[18]	Ministry of Health Malaysia. “Handbook for clinical management of dengue,” Putrajaya: Malaysia Health Technology Assessment Section (MaHTAS); 2015.
[19]	Ministry of Health Malaysia. “Clinical Practice Guidelines: Management of Dengue in Adults,” 3rd Edition. Putrajaya: Malaysia Health Technology Assessment Section (MaHTAS); 2015.
[20]	Valk De S, Olgers T, Holman M, Ismael F, Ligtenberg J, ter Maaten J. “The caval index: an adequate non-invasive ultrasound parameter to predict fluid responsiveness in the emergency department?,” BMC Anesthesiol. 2014; 14(1):114.
[21]	Martina B, Koraka P, Osterhaus A. “Dengue Virus Pathogenesis: an Integrated View,” Clinical Microbiology Reviews. 2009; 22(4): 564-581.
[22]	Sellahewa K. “Pathogenesis of Dengue Haemorrhagic Fever and Its Impact on Case Management,” ISRN Infectious Diseases. 2013; 2013: 1-6.
[23]	Wills B, Oragui E, Minh Dung N, Loan H, Chau N, Farrar J et al.” Size and Charge Characteristics of the Protein Leak in Dengue Shock Syndrome,” The Journal of Infectious Diseases. 2004; 190(4): 810-818.
[24]	World Health Organization: Dengue:”Guidelines for diagnosis, treatment, prevention and control,” Geneva: World Health Organization; 2009.
[25]	Carvalho de Macedo F, Nicol A, Cooper L, Yearsley M, Cordovil Pires A, Nuovo G. “Histologic, Viral, and Molecular Correlates of Dengue Fever Infection of the Liver Using Highly Sensitive Immunohistochemistry,” Diagnostic Molecular Pathology. 2006; 15(4): 223-228.
[26]	Sharp TM et al. “Fatal Hemophagocytic Lymphohistiocytosis Associated With Locally Acquired Dengue Virus Infection—New Mexico and Texas, 2012,” Annals of Emergency Medicine. 2014; 64(1): 55-57.
[27]	Rosado FG, Kim AS. “Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis,” Am J Clin Pathol. 2013 Jun; 139(6): 713-27.
[28]	Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S et al. “HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis,” Pediatr Blood Cancer. 2007 Feb; 48(2): 124-31.
[29]	Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G. “Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome,” Arthritis Rheumatol. 2014 Sep; 66(9): 2613-20.